Structure

Physi-Chem Properties

Molecular Weight:  458.15
Volume:  453.591
LogP:  4.963
LogD:  3.09
LogS:  -3.891
# Rotatable Bonds:  4
TPSA:  100.13
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.302
Synthetic Accessibility Score:  4.437
Fsp3:  0.4
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.804
MDCK Permeability:  1.2246466212673113e-05
Pgp-inhibitor:  0.007
Pgp-substrate:  0.04
Human Intestinal Absorption (HIA):  0.156
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.002

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.027
Plasma Protein Binding (PPB):  91.65230560302734%
Volume Distribution (VD):  0.841
Pgp-substrate:  6.3797807693481445%

ADMET: Metabolism

CYP1A2-inhibitor:  0.52
CYP1A2-substrate:  0.895
CYP2C19-inhibitor:  0.126
CYP2C19-substrate:  0.279
CYP2C9-inhibitor:  0.702
CYP2C9-substrate:  0.87
CYP2D6-inhibitor:  0.461
CYP2D6-substrate:  0.264
CYP3A4-inhibitor:  0.237
CYP3A4-substrate:  0.206

ADMET: Excretion

Clearance (CL):  1.632
Half-life (T1/2):  0.099

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.523
Drug-inuced Liver Injury (DILI):  0.885
AMES Toxicity:  0.569
Rat Oral Acute Toxicity:  0.547
Maximum Recommended Daily Dose:  0.886
Skin Sensitization:  0.377
Carcinogencity:  0.863
Eye Corrosion:  0.003
Eye Irritation:  0.122
Respiratory Toxicity:  0.127

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474004

Natural Product ID:  NPC474004
Common Name*:   15-Chlorotajixanthone Hydrate
IUPAC Name:   (1R,2S)-8-[(2S)-2-chloro-3-hydroxy-3-methylbutyl]-1,11-dihydroxy-5-methyl-2-prop-1-en-2-yl-2,3-dihydro-1H-pyrano[3,2-a]xanthen-12-one;hydrate
Synonyms:   15-Chlorotajixanthone Hydrate
Standard InCHIKey:  FTKJGBFCWTZCCQ-OKLLSCIYSA-N
Standard InCHI:  InChI=1S/C25H27ClO6.H2O/c1-11(2)14-10-31-23-12(3)8-16-19(20(23)21(14)28)22(29)18-15(27)7-6-13(24(18)32-16)9-17(26)25(4,5)30;/h6-8,14,17,21,27-28,30H,1,9-10H2,2-5H3;1H2/t14-,17+,21-;/m1./s1
SMILES:  CC(=C)[C@H]1COc2c([C@@H]1O)c1c(cc2C)oc2c(c1=O)c(O)ccc2C[C@@H](C(O)(C)C)Cl.O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL458017
PubChem CID:   44581697
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003518] 4-prenylated xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33058 emericella sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[17323993]
NPO33058 emericella sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[19013822]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1621 Individual Protein Calmodulin Homo sapiens IC50 = 9590.0 nM PMID[482665]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474004 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9434 High Similarity NPC186113
0.9379 High Similarity NPC473961
0.9182 High Similarity NPC135522
0.9152 High Similarity NPC225419
0.9042 High Similarity NPC241874
0.8916 High Similarity NPC477834
0.8896 High Similarity NPC44199
0.8882 High Similarity NPC474843
0.8862 High Similarity NPC178173
0.8827 High Similarity NPC178964
0.8827 High Similarity NPC280530
0.8827 High Similarity NPC95842
0.8805 High Similarity NPC71055
0.8788 High Similarity NPC471976
0.8765 High Similarity NPC87708
0.8758 High Similarity NPC227122
0.8758 High Similarity NPC202595
0.8735 High Similarity NPC3629
0.8704 High Similarity NPC232645
0.8704 High Similarity NPC72958
0.8698 High Similarity NPC6588
0.8698 High Similarity NPC477154
0.8698 High Similarity NPC117854
0.8696 High Similarity NPC473016
0.869 High Similarity NPC25361
0.8683 High Similarity NPC472402
0.8667 High Similarity NPC281137
0.8667 High Similarity NPC282390
0.8659 High Similarity NPC55662
0.8659 High Similarity NPC166054
0.865 High Similarity NPC281272
0.8642 High Similarity NPC37348
0.8642 High Similarity NPC471115
0.8642 High Similarity NPC472633
0.8642 High Similarity NPC29777
0.8639 High Similarity NPC120593
0.8634 High Similarity NPC5537
0.8631 High Similarity NPC207690
0.8631 High Similarity NPC197168
0.8625 High Similarity NPC469758
0.8623 High Similarity NPC18380
0.8623 High Similarity NPC137232
0.8613 High Similarity NPC324220
0.8613 High Similarity NPC312630
0.8606 High Similarity NPC164427
0.8605 High Similarity NPC154986
0.8598 High Similarity NPC169990
0.8598 High Similarity NPC329844
0.8598 High Similarity NPC210942
0.8589 High Similarity NPC473131
0.8589 High Similarity NPC478148
0.8589 High Similarity NPC470675
0.8589 High Similarity NPC207346
0.8589 High Similarity NPC149526
0.8589 High Similarity NPC474417
0.8589 High Similarity NPC46564
0.8588 High Similarity NPC474024
0.858 High Similarity NPC266499
0.8571 High Similarity NPC229632
0.8571 High Similarity NPC15374
0.8571 High Similarity NPC308200
0.8563 High Similarity NPC292863
0.8563 High Similarity NPC470810
0.8563 High Similarity NPC184326
0.8563 High Similarity NPC472618
0.8562 High Similarity NPC469764
0.8554 High Similarity NPC196448
0.8554 High Similarity NPC272196
0.8545 High Similarity NPC175192
0.8537 High Similarity NPC475790
0.8537 High Similarity NPC40356
0.8537 High Similarity NPC154683
0.8529 High Similarity NPC128293
0.8529 High Similarity NPC37870
0.8529 High Similarity NPC43319
0.8529 High Similarity NPC272502
0.8528 High Similarity NPC120105
0.8528 High Similarity NPC101957
0.8521 High Similarity NPC273959
0.8521 High Similarity NPC290160
0.8521 High Similarity NPC236521
0.8521 High Similarity NPC152659
0.8521 High Similarity NPC248638
0.8519 High Similarity NPC37135
0.8519 High Similarity NPC39195
0.8519 High Similarity NPC145467
0.8519 High Similarity NPC186397
0.8512 High Similarity NPC474187
0.8512 High Similarity NPC474186
0.8509 High Similarity NPC24136
0.8509 High Similarity NPC473132
0.8509 High Similarity NPC290133
0.8509 High Similarity NPC472629
0.8509 High Similarity NPC473135
0.8509 High Similarity NPC470676
0.8509 High Similarity NPC187282
0.8503 High Similarity NPC329091
0.8503 High Similarity NPC472617
0.8503 High Similarity NPC195167
0.8503 High Similarity NPC85121
0.8503 High Similarity NPC226287
0.8488 Intermediate Similarity NPC103307
0.8488 Intermediate Similarity NPC241387
0.8488 Intermediate Similarity NPC251144
0.8485 Intermediate Similarity NPC477691
0.8485 Intermediate Similarity NPC193200
0.848 Intermediate Similarity NPC218226
0.8476 Intermediate Similarity NPC470569
0.8476 Intermediate Similarity NPC474023
0.8476 Intermediate Similarity NPC474021
0.8476 Intermediate Similarity NPC39819
0.8471 Intermediate Similarity NPC239752
0.8471 Intermediate Similarity NPC293319
0.8471 Intermediate Similarity NPC472450
0.8471 Intermediate Similarity NPC275780
0.8466 Intermediate Similarity NPC158338
0.8466 Intermediate Similarity NPC10027
0.8466 Intermediate Similarity NPC97028
0.8466 Intermediate Similarity NPC288036
0.8466 Intermediate Similarity NPC329933
0.8466 Intermediate Similarity NPC65775
0.8466 Intermediate Similarity NPC100985
0.8466 Intermediate Similarity NPC65589
0.8466 Intermediate Similarity NPC97029
0.8466 Intermediate Similarity NPC471114
0.8466 Intermediate Similarity NPC5173
0.8466 Intermediate Similarity NPC223988
0.8462 Intermediate Similarity NPC329760
0.8462 Intermediate Similarity NPC52204
0.8462 Intermediate Similarity NPC25152
0.8462 Intermediate Similarity NPC473022
0.8457 Intermediate Similarity NPC477683
0.8457 Intermediate Similarity NPC473077
0.8457 Intermediate Similarity NPC477682
0.8457 Intermediate Similarity NPC296998
0.8452 Intermediate Similarity NPC475886
0.8452 Intermediate Similarity NPC321399
0.8452 Intermediate Similarity NPC474287
0.8452 Intermediate Similarity NPC284495
0.8452 Intermediate Similarity NPC119224
0.8447 Intermediate Similarity NPC470890
0.8447 Intermediate Similarity NPC271288
0.8447 Intermediate Similarity NPC124780
0.8447 Intermediate Similarity NPC311144
0.8447 Intermediate Similarity NPC131568
0.8447 Intermediate Similarity NPC87486
0.8447 Intermediate Similarity NPC131579
0.8443 Intermediate Similarity NPC217677
0.8443 Intermediate Similarity NPC475184
0.8443 Intermediate Similarity NPC165977
0.8443 Intermediate Similarity NPC471209
0.8439 Intermediate Similarity NPC472620
0.8434 Intermediate Similarity NPC477958
0.8434 Intermediate Similarity NPC68727
0.8434 Intermediate Similarity NPC275575
0.843 Intermediate Similarity NPC297195
0.843 Intermediate Similarity NPC207574
0.843 Intermediate Similarity NPC291795
0.8424 Intermediate Similarity NPC477690
0.8424 Intermediate Similarity NPC51824
0.8424 Intermediate Similarity NPC217447
0.8424 Intermediate Similarity NPC470340
0.8424 Intermediate Similarity NPC253904
0.8424 Intermediate Similarity NPC273483
0.8424 Intermediate Similarity NPC268992
0.8424 Intermediate Similarity NPC321363
0.8424 Intermediate Similarity NPC113608
0.8424 Intermediate Similarity NPC470338
0.8424 Intermediate Similarity NPC142527
0.8424 Intermediate Similarity NPC470337
0.8421 Intermediate Similarity NPC170245
0.8421 Intermediate Similarity NPC39091
0.8421 Intermediate Similarity NPC173292
0.8421 Intermediate Similarity NPC251336
0.8421 Intermediate Similarity NPC472449
0.8415 Intermediate Similarity NPC255641
0.8415 Intermediate Similarity NPC294646
0.8415 Intermediate Similarity NPC470568
0.8415 Intermediate Similarity NPC290954
0.8415 Intermediate Similarity NPC147735
0.8412 Intermediate Similarity NPC7483
0.8412 Intermediate Similarity NPC236132
0.8412 Intermediate Similarity NPC189473
0.8412 Intermediate Similarity NPC23298
0.8412 Intermediate Similarity NPC100849
0.8412 Intermediate Similarity NPC186686
0.8405 Intermediate Similarity NPC256672
0.8405 Intermediate Similarity NPC106328
0.8405 Intermediate Similarity NPC191634
0.8405 Intermediate Similarity NPC27221
0.8405 Intermediate Similarity NPC7025
0.8405 Intermediate Similarity NPC35150
0.8402 Intermediate Similarity NPC475883
0.8402 Intermediate Similarity NPC66288
0.8402 Intermediate Similarity NPC472632
0.8402 Intermediate Similarity NPC32694
0.8402 Intermediate Similarity NPC474351
0.8402 Intermediate Similarity NPC61010
0.84 Intermediate Similarity NPC475246
0.8395 Intermediate Similarity NPC54577

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474004 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8512 High Similarity NPD6959 Discontinued
0.8263 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD5494 Approved
0.8214 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8155 Intermediate Similarity NPD7819 Suspended
0.8114 Intermediate Similarity NPD5844 Phase 1
0.811 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8084 Intermediate Similarity NPD4380 Phase 2
0.8012 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD1934 Approved
0.7963 Intermediate Similarity NPD1549 Phase 2
0.7943 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7943 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7943 Intermediate Similarity NPD6166 Phase 2
0.7941 Intermediate Similarity NPD2801 Approved
0.7898 Intermediate Similarity NPD7473 Discontinued
0.7892 Intermediate Similarity NPD2534 Approved
0.7892 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD2532 Approved
0.7892 Intermediate Similarity NPD2533 Approved
0.7877 Intermediate Similarity NPD6559 Discontinued
0.7829 Intermediate Similarity NPD6232 Discontinued
0.7824 Intermediate Similarity NPD7411 Suspended
0.7809 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD7075 Discontinued
0.7796 Intermediate Similarity NPD4363 Phase 3
0.7796 Intermediate Similarity NPD4360 Phase 2
0.7791 Intermediate Similarity NPD5402 Approved
0.7791 Intermediate Similarity NPD2346 Discontinued
0.779 Intermediate Similarity NPD8313 Approved
0.779 Intermediate Similarity NPD8312 Approved
0.7784 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD7074 Phase 3
0.7758 Intermediate Similarity NPD3750 Approved
0.7746 Intermediate Similarity NPD7768 Phase 2
0.7733 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD2796 Approved
0.773 Intermediate Similarity NPD2935 Discontinued
0.7709 Intermediate Similarity NPD7054 Approved
0.7706 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD3226 Approved
0.7701 Intermediate Similarity NPD3749 Approved
0.7669 Intermediate Similarity NPD1510 Phase 2
0.7667 Intermediate Similarity NPD7472 Approved
0.7654 Intermediate Similarity NPD1607 Approved
0.764 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7637 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD6797 Phase 2
0.7622 Intermediate Similarity NPD6099 Approved
0.7622 Intermediate Similarity NPD6100 Approved
0.7619 Intermediate Similarity NPD1511 Approved
0.7582 Intermediate Similarity NPD7251 Discontinued
0.7572 Intermediate Similarity NPD6801 Discontinued
0.7562 Intermediate Similarity NPD4625 Phase 3
0.7561 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD3818 Discontinued
0.7545 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD3882 Suspended
0.7541 Intermediate Similarity NPD7808 Phase 3
0.7531 Intermediate Similarity NPD1240 Approved
0.7529 Intermediate Similarity NPD1512 Approved
0.7516 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD7390 Discontinued
0.7515 Intermediate Similarity NPD1551 Phase 2
0.75 Intermediate Similarity NPD6781 Approved
0.75 Intermediate Similarity NPD6776 Approved
0.75 Intermediate Similarity NPD6780 Approved
0.75 Intermediate Similarity NPD6778 Approved
0.75 Intermediate Similarity NPD6779 Approved
0.75 Intermediate Similarity NPD6782 Approved
0.75 Intermediate Similarity NPD6777 Approved
0.7485 Intermediate Similarity NPD2800 Approved
0.7474 Intermediate Similarity NPD7698 Approved
0.7474 Intermediate Similarity NPD7696 Phase 3
0.7474 Intermediate Similarity NPD7697 Approved
0.7457 Intermediate Similarity NPD6599 Discontinued
0.7455 Intermediate Similarity NPD3748 Approved
0.7455 Intermediate Similarity NPD2799 Discontinued
0.743 Intermediate Similarity NPD5710 Approved
0.743 Intermediate Similarity NPD5711 Approved
0.7423 Intermediate Similarity NPD6823 Phase 2
0.7394 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD4908 Phase 1
0.7387 Intermediate Similarity NPD7783 Phase 2
0.7387 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD3817 Phase 2
0.7385 Intermediate Similarity NPD7435 Discontinued
0.7384 Intermediate Similarity NPD5403 Approved
0.7382 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD4361 Phase 2
0.738 Intermediate Similarity NPD8150 Discontinued
0.7368 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD3751 Discontinued
0.7351 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD7871 Phase 2
0.7347 Intermediate Similarity NPD7870 Phase 2
0.7337 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD3787 Discontinued
0.733 Intermediate Similarity NPD1465 Phase 2
0.7323 Intermediate Similarity NPD7701 Phase 2
0.731 Intermediate Similarity NPD6799 Approved
0.7301 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6844 Discontinued
0.7273 Intermediate Similarity NPD37 Approved
0.7273 Intermediate Similarity NPD5124 Phase 1
0.7273 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7228 Approved
0.7267 Intermediate Similarity NPD5401 Approved
0.7247 Intermediate Similarity NPD4967 Phase 2
0.7247 Intermediate Similarity NPD4966 Approved
0.7247 Intermediate Similarity NPD4965 Approved
0.724 Intermediate Similarity NPD6535 Approved
0.724 Intermediate Similarity NPD6534 Approved
0.7235 Intermediate Similarity NPD4628 Phase 3
0.7235 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD6273 Approved
0.7222 Intermediate Similarity NPD2861 Phase 2
0.7216 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD7700 Phase 2
0.7216 Intermediate Similarity NPD7699 Phase 2
0.7214 Intermediate Similarity NPD7801 Approved
0.7202 Intermediate Similarity NPD5406 Approved
0.7202 Intermediate Similarity NPD5408 Approved
0.7202 Intermediate Similarity NPD5405 Approved
0.7202 Intermediate Similarity NPD5404 Approved
0.72 Intermediate Similarity NPD8151 Discontinued
0.7195 Intermediate Similarity NPD2313 Discontinued
0.7188 Intermediate Similarity NPD4749 Approved
0.7184 Intermediate Similarity NPD920 Approved
0.7182 Intermediate Similarity NPD1247 Approved
0.7176 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD1610 Phase 2
0.7168 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD6234 Discontinued
0.7164 Intermediate Similarity NPD7874 Approved
0.7164 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD2403 Approved
0.7151 Intermediate Similarity NPD5953 Discontinued
0.7143 Intermediate Similarity NPD7229 Phase 3
0.7143 Intermediate Similarity NPD2370 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7003 Approved
0.7135 Intermediate Similarity NPD7286 Phase 2
0.7126 Intermediate Similarity NPD6651 Approved
0.7108 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD1613 Approved
0.7105 Intermediate Similarity NPD8434 Phase 2
0.7099 Intermediate Similarity NPD1470 Approved
0.7091 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1201 Approved
0.7059 Intermediate Similarity NPD2344 Approved
0.7056 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD5761 Phase 2
0.7039 Intermediate Similarity NPD5760 Phase 2
0.7 Intermediate Similarity NPD8320 Phase 1
0.7 Intermediate Similarity NPD8319 Approved
0.6977 Remote Similarity NPD1243 Approved
0.6954 Remote Similarity NPD643 Clinical (unspecified phase)
0.6951 Remote Similarity NPD2798 Approved
0.6944 Remote Similarity NPD8455 Phase 2
0.6941 Remote Similarity NPD4308 Phase 3
0.6941 Remote Similarity NPD7033 Discontinued
0.6933 Remote Similarity NPD1283 Approved
0.6931 Remote Similarity NPD7240 Approved
0.6923 Remote Similarity NPD6213 Phase 3
0.6923 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6212 Phase 3
0.6919 Remote Similarity NPD2424 Discontinued
0.6919 Remote Similarity NPD3926 Phase 2
0.6914 Remote Similarity NPD7041 Phase 2
0.6914 Remote Similarity NPD7040 Clinical (unspecified phase)
0.691 Remote Similarity NPD7458 Discontinued
0.6906 Remote Similarity NPD4288 Approved
0.6905 Remote Similarity NPD943 Approved
0.6905 Remote Similarity NPD4060 Phase 1
0.6905 Remote Similarity NPD2979 Phase 3
0.6902 Remote Similarity NPD7199 Phase 2
0.6898 Remote Similarity NPD7177 Discontinued
0.6897 Remote Similarity NPD2309 Approved
0.689 Remote Similarity NPD2797 Approved
0.689 Remote Similarity NPD1203 Approved
0.6886 Remote Similarity NPD3764 Approved
0.6886 Remote Similarity NPD3268 Approved
0.6885 Remote Similarity NPD919 Approved
0.6882 Remote Similarity NPD4536 Approved
0.6882 Remote Similarity NPD4538 Approved
0.6882 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6784 Approved
0.6875 Remote Similarity NPD1651 Approved
0.6875 Remote Similarity NPD6785 Approved
0.6867 Remote Similarity NPD6832 Phase 2
0.6867 Remote Similarity NPD1529 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data